目前仍不清楚早期应用肾素血管紧张素抑制剂能否减缓病变进程。
It is unclear whether their progression is slowed by early administration of drugs that block the renin-angiotensin system.
研究结论：对1型糖尿病患者早期应用肾素血管紧张素抑制剂并不能缓解糖尿病肾病的进展但可以减缓视网膜病变。
Conclusions Early blockade of the renin-angiotensin system in patients with type 1 diabetes did not slow nephropathy progression but slowed the progression of retinopathy.
CHARM研究探讨了肾素-血管紧张素抑制剂的递增策略，通过在背景治疗的基础上包括ARB增添了ACE抑制剂。
The CHARM study looked at a strategy of incremental renin-angiotensin inhibition but did it by adding an ARB to background therapy that included ACE inhibitors.
ACE抑制剂的工作，通过抑制血管紧张素I的转化可以强化血管，血管紧张素Ⅱ可改善血流和血压。
ACE inhibitors work by inhibiting the conversion of angiotensin I to the potent vasoconstrictor, angiotensin II, thereby improving blood flow and blood pressure.
使用量数据显示，利尿剂和血管紧张素转换酶抑制剂是最常供应的药物(分别为42%和27%)，符合南非降压治疗指南。
Supply data showed that, in line with treatment guidelines, diuretics and angiotensin-converting enzyme inhibitors were the most frequently supplied medicines (42% and 27%, respectively).
血压控制药物血管紧张素转化酶抑制剂(acei)可以降低血压，并减少蛋白质从尿中的排泄。
Blood pressure medications. Drugs called angiotensin-converting enzyme inhibitors reduce blood pressure and also reduce the amount of protein released in urine.
血管紧张素转化酶(ace)抑制剂。
本品是一种血管紧张素转换酶抑制剂。
目的：探讨应用血管紧张素转化酶抑制剂(acei)治疗心血管疾病时引起急性肾衰竭和高钾血症的原因及其应对方法。
OBJECTIVE: To study the reasons for acute renal failure (ARF) and hyperkalemia caused by ACEI which is used for treating cardiovascular disease, and the dealing method.
醛固酮抑制剂和血管紧张素转换酶抑制剂可辅助阻断RAAS，并有助于防止远端肾小管钾的损失。身体保钾，这样可减少口服补钾量。
Aldosterone inhibitors and ACE inhibitors help block the RAAS and help prevent potassium loss in the distal tubules. The body conserves potassium, and less oral potassium supplementation is needed.
血管紧张素转化酶抑制剂是治疗高血压和心脏衰竭的一种治疗方式。
ACE inhibitors are a type of medication used to treat high blood pressure and heart failure.
用瑞士乳杆菌生产具有抑制血管紧张素转换酶（ACE）活性的发酵乳并从其中分离血管紧张素转换酶抑制剂（ACEI）。
To produce fermented milk that can inhibit the activity of angiotensin converting enzyme(ACE), then the angiotensin converting enzyme inhibitor(ACEI) can be purified from the fermented milk.
目的评价血管紧张素转换酶抑制剂（ACEI）卡托普利对缺血心肌的药理作用。
Objective To evaluate the pharmaceutical effect of angiotensin-converting enzyme inhibitor(ACEI) captopril on ischemic myocardium.
目的研究血管紧张素转换酶抑制剂(acei)和血管紧张素受体拮抗剂(arb)对2型糖尿病肾病患者肾功能的保护作用。
Objective to investigate the protective effect of angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor antagonist (ARB) on renal function of type 2 diabetic nephropathy patients.
报道一种用反相hplc技术简便、有效地研究心血管紧张素转化酶抑制剂体外抑制动力学的新方法。
A simple reversed_phase HPLC method for the study of in_vitro inhibition kinetics of angiotensin_converting enzyme inhibitors is described.
但是，在卒中后立即应用肾素——血管紧张素系统抑制剂降低血压的作用尚不清楚。
However, the effect of lowering of blood pressure with a renin-angiotensin system inhibitor soon after a stroke has not been clearly established.
目的：研究阿司匹林和血管紧张素转换酶抑制剂(acei)联合使用对急性心肌梗塞(ami)患者病死率的影响。
Objective: This study was to evaluate the clinical effects of angiotensin converting enzyme inhibitors (ACEI) with aspirin treatment for acute myocardial infarction (AMI).
目的观察血管紧张素转换酶抑制剂苯那普利减轻幼龄肾病大鼠蛋白尿的作用。
Objective To observe the effect of benazepril, an angiotensin converting enzyme inhibitor (ACEI) , on reducing proteinuria in a nephrotic young rat model of with massive proteinuria.
血管紧张素转化酶抑制剂和血管紧张素受体拮抗剂联合用药治疗CKD是否比单药应用要好？
Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination therapy Better Than Monotherapy and Safe in Patients With CKD?
近年来，许多学者对血管紧张素转化酶抑制剂抑制率的测定方法开展了大量的研究工作。
A lot of research work has been carried out about the analytical method for inhibitory activity of the angiotensin-converting enzyme in recent years.
目的了解慢性肾衰(CRF)患者应用转换酶抑制剂(acei)后血浆心钠素(ANF)和肾素-血管紧张素系统(RAS)激素的相互影响。
Objective to study the interaction of renin-angiotensin system (RAS) and atrial natriuretic factor (ANF) under acute angiotensin converting enzyme inhibitors (ACEI) in chronic renal failure (CRF).
目的观察血管紧张素转换酶抑制剂(acei)减少急性心肌梗塞(ami)后患者心肌缺血及其相关事件的影响。
AIM to study the effect of angiotensin converting inhibitor (ACEI) reduces myocardial ischemia and related events after acute myocardial infarction (AMI).
ACE抑制剂应与血管紧张素受体拮抗剂合用吗？
Should ACE Inhibitors be Combined with Angiotensin II Receptor Antagonists?
对第二代血管紧张素转化酶抑制剂依那普利的药理作用及临床应用作一简要综述。
The purest of the writing is to summarize the pharmacal effect and clinical practice of the second angiotensin - converting enzyme inhibitors enalapril.
将抑制50%的血管紧张素转换酶活性所需抑制剂浓度定义为IC 50。
The concentration of ACE inhibitors needed to inhibit 50% of ACE activity was defined as the IC50 value.
而那些能降低房颤发病的因素有胸痛(OR 0.35)，非白种人(OR 0.61)，糖尿病(OR 0.67)和血管紧张素转换酶抑制剂的应用(OR 0.63)。
Factors that significantly reduced AF onset included chest pain (or 0.35), non-Caucasian race (or 0.61), diabetes (or 0.67) and ace inhibitor use (or 0.63).
结论应用血管紧张素转换酶抑制剂(acei)治疗原发性高血压时，宜首选培哚普利。
Conclusion it is suggested that perindopril should be the first choice when angiotensin converting enzyme inhibitor (ACEI) is taken into account for the therapy of primary hypertension.
目的探讨凋亡基因对大鼠心肌梗死的表达及血管紧张素转化酶抑制剂(acei)的干预作用。
Objective to investigate the expression of apoptosis - related genes in rats with myocardial infarction and effects of ACEI.
目的探讨犬急性心功能不全状态下肾动脉血流和肾微血管床血流灌注的改变及血管紧张素转换酶抑制剂对其影响。
Objective to investigate the changes and the effects of captopril on the renal blood flow and microvascular perfusion in dogs with acute cardiac insufficiency.
血管紧张素转换酶抑制剂(acei)治疗后冠心病组各型肱动脉内皮依赖性舒张功能与治疗前比较均有显著性改善，其中DD基因型改善最为明显。
After the therapy with angiotensin converting enzyme inhibitor (ACEI), the endothelium-dependent vasodilation function was improved in the coronary groups and especially for the DD group.
应用推荐